Funds and ETFs Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
429.9 USD | +1.69% | +6.81% | +5.66% |
05-10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
05-07 | FOMO is Back |
ETFs positioned on Vertex Pharmaceuticals Incorporated
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 34 M€ | +3.39% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.66% | 111B | |
+11.23% | 105B | |
-2.47% | 21.93B | |
-12.15% | 22.34B | |
-5.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B | |
+288.77% | 7.98B |
- Stock Market
- Equities
- VRTX Stock
- Funds and ETFs Vertex Pharmaceuticals Incorporated